| Ytd | -18.11% | |
| 1y | -30.41% |
| Open | 53.22 | Prev Close | 52.58 | Low | 52.56 | High | 53.52 | Mkt Cap | 4.97B |
| Vol | 933.67K | Avg Vol | 802.99K | EPS | 2.52 | P/E | 20.87 | Forward P/E | 11.42 |
| Beta | 0.80 | Short Ratio | 7.27 | Inst. Own | 101.65% | Dividend | 1.41 | Div Yield | 2.68 |
| Ex Div Date | 05-12 | Earning | 04-30 | 50-d Avg | 56.01 | 200-d Avg | 63.14 | 1yr Est | 78.33 |
DLB News
Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FD
U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on
Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. se
Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.
Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst
Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.
Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.2
Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. se
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolb
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t
Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate
Dolby Laboratories (NYSE:DLB) is looking for Q1 Adj EPS of $0.79-$0.94 vs $1.14 analyst estimate. se
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.99 per share which beat the analyst
https://engineering.fb.com/2025/11/17/ios/enhancing-hdr-on-instagram-for-ios-with-dolby-vision/
Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo
Baird analyst Vikram Kesavabhotla initiates coverage on Dolby Laboratories (NYSE:DLB) with a Neut
Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and ra
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
Dolby Laboratories (NYSE:DLB) affirms FY2025 Adj EPS guidance from $3.88-$4.03 to $3.88-$4.03 vs $3.
Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $0.61-$0.76 vs $0.77 analyst estimate. se
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.78 per share which beat the analyst
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintain
Tigress Financial analyst Ivan Feinseth maintains Dolby Laboratories (NYSE:DLB) with a Buy and lo
Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperfo
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers t
Dolby Laboratories (NYSE:DLB) lowers FY2025 GAAP EPS guidance from $2.39-$2.54 to $2.31-$2.46 vs $2.
Dolby Laboratories (NYSE:DLB) lowers FY2025 Adj EPS guidance from $3.99-$4.14 to $3.88-$4.03 vs $4.0
Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.62-$0.77 vs $0.81 analyst estimate. se